Isodiol International Inc. Provides Update on Be Tru Wellness, Announces New Distribution Agreement With Threshold Enterprises

Isodiol International Inc. (CSE:ISOL) (OTC:ISOLF) (FSE:LB6A.F) (the “Company” or “Isodiol”), a global Bioactive CBD innovator specializing in the development of pharmaceutical and wellness products, is pleased to announce that its wholly owned

Isodiol International Inc. Announces Partnership With Europe’s Leading MMA Promotion, Cage Warriors; ISO-Sport Product Line to Commence Sales in the European Market

Isodiol International Inc. (CSE:ISOL) (OTC:ISOLF) (FSE:LB6A.F), a global CBD innovator specializing in the development of wellness products, proudly announces that it has reached a partnership agreement with 

Isodiol International Inc. Announces Licensing Agreement With Livecare Health Canada Inc. and Appoints Dr. Amit Mathur to Medical Advisory Board

Isodiol International Inc. (CSE:ISOL) (OTC:ISOLF) (FSE:LB6A.F) (the “Company” or “Isodiol”), a global Bioactive Phytoceutical innovator specializing in the development of pharmaceutical and wellness products, is pleased to announce that it has

Isodiol International Inc. Announces Extension of Licensing Agreement with Kathy Ireland and Level Brands

Isodiol International Inc., (CSE:ISOL) (OTC:ISOLF) (FSE:LB6A.F) (the “Company” or “Isodiol”), a global bioactive phytoceutical innovator specializing in the development of pharmaceutical and wellness products, announced today that it has signed an amendment to the

Isodiol Continues To Expand Through Strategic Acquisitions And Partnerships

On Friday, the cannabis sector recorded volatile price movements and rallied well off its early morning lows.

We are favorable on this move higher and the volatility comes after United States Attorney General Jeff Sessions rescinded the Cole Memo, which protected the legal cannabis industry.

Pages